Haus O, Kozłowska J, Zubkiewicz L, Jagielski J, Kotlarek-Haus S
Katedry i Zakładu Patofizjologii AM we Wrocławiu.
Pol Arch Med Wewn. 1991 Sep;86(3):132-41.
Cytogenetic examinations were carried out in 24 untreated patients with non-Hodgkin, non-Burkitt lymphoma. 10-20 G-banded metaphases, obtained from short-term cultures of unstimulated lymph++ node, bone marrow and blood cells were analyzed in each case. In 18 patients only, the obtained metaphases were suitable for cytogenetic analysis. In 11 patients (group A) karyotype was normal or only single, +non-clonal aberrations were observed. In 7 patients (group B) clonal aberrations were found, among them, in 3-structural changes of chromosome 1, but with different breakpoints: 1p31, 1p31, 1p36. The group of patients with chromosomal aberrations showed statistically significantly shorter survival time than the group without aberrations (p = 0.04). In the former group more patients had low grade malignancy lymphoma. Our observations confirm those data from the literature which indicate that the presence of chromosomal aberrations is a factor of poor prognosis, independent of other clinical and histopathological prognostic factors in non-Hodgkin Lymphoma.
对24例未经治疗的非霍奇金、非伯基特淋巴瘤患者进行了细胞遗传学检查。每例均分析了10 - 20个经G显带的中期分裂相,这些中期分裂相取自未受刺激的淋巴结、骨髓和血细胞的短期培养物。仅18例患者所获得的中期分裂相适合进行细胞遗传学分析。11例患者(A组)核型正常或仅观察到单个非克隆性畸变。7例患者(B组)发现有克隆性畸变,其中3例染色体1有结构改变,但断裂点不同:1p31、1p31、1p36。有染色体畸变的患者组生存时间在统计学上显著短于无畸变的患者组(p = 0.04)。在前一组中,更多患者患有低级别恶性淋巴瘤。我们的观察结果证实了文献中的那些数据,这些数据表明染色体畸变的存在是预后不良的一个因素,独立于非霍奇金淋巴瘤的其他临床和组织病理学预后因素。